ProFuse Technology News
5 articles
growth-positive
/PRNewswire/ -- Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory conditions, has launched a new...
ProFuse Technology, an Israeli startup, has launched a new technology aimed at discovering drugs to prevent muscle mass loss caused by GLP-1 weight-loss injections, aging, and cancer. The company uses advanced automation to efficiently screen potential drug candidates, reducing the need for extensive animal testing. The demand for muscle-preserving therapies is increasing, with significant health concerns associated with muscle loss from GLP-1 treatments. ProFuse has raised approximately $8 million, including $3 million in grants from the EU and Israel Innovation Authority. The company also announced the appointment of Anat Naschitz to its Board of Directors, highlighting its strategic growth and adaptability in the life sciences field.
InvestmentManagement Changes
Israel startup gets EU backing to help bring lab-grown meat cuts to table
growth-positive
Profuse Technology Secures $2.5 million in Seed Funding to Reduce Costs of Cultivated Meat Production
Israeli Foodtech start-up Profuse Technology has completed a $2.5m seed funding round, bringing its total funding to $3.75m. The funding will be used to collaborate with cultivated meat producers, obtain FDA regulatory approval, expand the research and development team, and position the company for further capital raising in Q2 2023. Profuse Technology aims to revolutionize cultivated meat production by shortening its duration, improving its quality, and increasing yields. The companys technology is based on six years of research conducted at the Weizmann Institute of Science. The goal is to achieve price parity between cultivated meat and animal-based meat, with plans to sell products as early as mid-2023. The company has cooperation agreements with leading cultivated meat companies.
InvestmentExpand
growth-positive
ProFuse Technology Raises $1.25M in Funding
ProFuse Technology, a food tech startup based in Israel, has raised $1.25M in funding. The company has developed technology that accelerates muscle fiber growth in cultured meat, reducing production time and enhancing production capacity. The technology is based on 6 years of research conducted at the Weizmann Institute of Science. ProFuse Technology was established by Fresh Start FoodTech and is supported by The Israeli Innovation Authority, Tnuva, Tempo, OurCrowds investment platform, and Finistere Ventures. The company began operations in June 2021 under the leadership of Dr. Tamar Eigler Hirsch (CTO) and Mr. Guy N. Michrowski (CEO).
Investment
growth-positive
פרופיוז טכנולוגיות זכתה למימון של כ-4 מיליון ש"ח מחממת פרש סטארט New-Tech OnLine
פרופיוז טכנולוגיות, a food technology company, has developed an innovative solution to optimize the production of cultured meat. The companys technology, based on research conducted at the Weizmann Institute of Science, improves muscle cell sorting and fusion, resulting in increased production efficiency and reduced costs. The company aims to provide significant value to cultured meat manufacturers and promote price parity with traditional agricultural meat. Founded by experts in cardiovascular and blood vessel development, ProFuse Technology is supported by the Innovation Authority and operated by a consortium of Tnuva, Tempo, OurCrowd, and Finistere Ventures. The company plans to collaborate with startups in the food industry to advance sustainable food production. The article highlights the companys unique expertise in muscle cell optimization and its potential to revolutionize the cultured meat industry.
PartnersInvestment
